Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer

Avantika Gupta; Andrea Gazzo; Pier Selenica; Anton Safonov; Fresia Pareja; Edaise M da Silva; David N Brown; Hong Shao; Yingjie Zhu; Juber Patel; Juan Blanco-Heredia; Bojana Stefanovska; Michael A Carpenter; Yanjun Chen; Isabella Vegas; Xin Pei; Denise Frosina; Achim A Jungbluth; Marc Ladanyi; Giuseppe Curigliano; Britta Weigelt; Nadeem Riaz; Simon N Powell; Pedram Razavi; Reuben S Harris; Jorge S Reis-Filho; Antonio Marra; Sarat Chandarlapaty

doi:10.1038/s41588-025-02471-0

Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer

Nat Genet. 2026 Jan;58(1):232. doi: 10.1038/s41588-025-02471-0.

Authors

Avantika Gupta^#¹, Andrea Gazzo^#², Pier Selenica², Anton Safonov³, Fresia Pareja², Edaise M da Silva², David N Brown², Hong Shao¹, Yingjie Zhu², Juber Patel², Juan Blanco-Heredia², Bojana Stefanovska^{4

5}, Michael A Carpenter^{4

5}, Yanjun Chen⁴, Isabella Vegas¹, Xin Pei⁶, Denise Frosina², Achim A Jungbluth², Marc Ladanyi², Giuseppe Curigliano^{7

8}, Britta Weigelt², Nadeem Riaz⁶, Simon N Powell⁶, Pedram Razavi^{3

9}, Reuben S Harris^{4

5}, Jorge S Reis-Filho², Antonio Marra^{10

11

12}, Sarat Chandarlapaty^{13

14

15}

Affiliations

¹ Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁴ Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.
⁵ Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX, USA.
⁶ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.
⁸ Early Drug Development for Innovative Therapies, European Institute of Oncology IRCSS, Milan, Italy.
⁹ Weill-Cornell Medical College, New York, NY, USA.
¹⁰ Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. antonio.marra@ieo.it.
¹¹ Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy. antonio.marra@ieo.it.
¹² Early Drug Development for Innovative Therapies, European Institute of Oncology IRCSS, Milan, Italy. antonio.marra@ieo.it.
¹³ Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chandars@mskcc.org.
¹⁴ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. chandars@mskcc.org.
¹⁵ Weill-Cornell Medical College, New York, NY, USA. chandars@mskcc.org.

^# Contributed equally.

No abstract available

Publication types

Published Erratum